BELLUS Health (BELLUS Health) Debt-to-Asset : 0.00 (As of Mar. 2023)

View and export this data going back to 2000. Start your Free Trial

What is BELLUS Health Debt-to-Asset?

BELLUS Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $0.37 Mil. BELLUS Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $0.83 Mil. BELLUS Health's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2023 was $379.54 Mil. BELLUS Health's debt to asset for the quarter that ended in Mar. 2023 was 0.00.

BELLUS Health Debt-to-Asset Historical Data

The historical data trend for BELLUS Health's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BELLUS Health Debt-to-Asset Chart

BELLUS Health Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

Get a 7-Day Free Trial

BELLUS Health Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Debt-to-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BELLUS Health's Debt-to-Asset

For the Biotechnology subindustry, BELLUS Health's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BELLUS Health's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BELLUS Health's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BELLUS Health's Debt-to-Asset falls into.

BELLUS Health Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BELLUS Health's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.351	+	0.932)	/	407.82
	=	0.00

BELLUS Health's Debt-to-Asset for the quarter that ended in Mar. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.365	+	0.834)	/	379.543
	=	0.00

BELLUS Health (NAS:BLU) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

BELLUS Health Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of BELLUS Health's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

BELLUS Health (BELLUS Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BELLUS Health Inc (NAS:BLU) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

275 Armand-Frappier Boulevard, Laval, QC, CAN, H7V 4A7

Website

http://www.bellushealth.com

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.